Healthcare Near Patient Molecular Solution Market | Page 2

REPORT DESCRIPTION
Near Patient Molecular Solution Market – Overview
Near patient molecular solution, also called point-of-care diagnosis, is a technology that helps diagnose and
monitor health at the convenience of the patient. There are various innovations in healthcare such as basic
health monitoring smartphone apps, wearable devices, and biosensors, which provide ease to patient in
monitoring their health. The motive is to provide patients with easy access to testing solutions, with quick
turnaround time and accurate results as opposed to that offered by conventional lab-based tests.
Increasing incidence of diseases such as cardiac disorders and diabetes in developing countries, growing
preference for home-based point-of-care devices, advancements in technology, and wide availability of
easy to use devices are spurring growth of the near patient molecular solution market. According to the
institute for Health Metrics and Evaluation (IHME), the number of deaths due to cardiovascular diseases
worldwide increased by 41% between 1990 and 2013, from 12.3 million to 17.3 million deaths. South Asia
experienced the largest increase in total deaths, with 1.8 million more deaths in 2013 than in 1990—an
alarming increase of 97%.